Logo-ijhpm
Int J Health Policy Manag. 2022;11(7): 990-1000. doi: 10.34172/ijhpm.2020.243
PMID: 33590736        PMCID: PMC9808195

Original Article

Evaluation of Pharmacovigilance System in Iran

Malahat Khalili 1 ORCID, Hamid Sharifi 1 ORCID, Bita Mesgarpour 2 ORCID, Mehrnaz Kheirandish 3 ORCID, Sten Olsson 4,5 ORCID, Naghmeh Javidnikou, Ali Akbar Haghdoost 1 * ORCID

Cited by CrossRef:

1- Ezeodimegwu A, Iloabuchi F, Onyia I, Eze C, Ezenri G, Onyekwuo P, Ihemegbulam C, Isah A. Assessment of the State of Pharmacovigilance in Secondary Hospitals in the Federal Capital Territory of Nigeria, Using WHO Pharmacovigilance Indicators. Ther Innov Regul Sci. 2024;58(6):1148 [Crossref]
2- khatereh A, Koruosh G, Alireza T, Daryuosh J, Parastoo B. Adverse Events Following Immunizations in Infants Under 1 Year of Age in Lorestan Province, Western Iran. J Prev Med Public Health. 2023;56(2):172 [Crossref]
3- Mongkhonmath N, Olson P, Puttarak P, Keokinnaly S, Sawangjit R. Effectiveness of the modified TaWai mobile application for reporting adverse drug reaction in Lao PDR: a cluster randomized controlled trial. Sci Rep. 2024;14(1) [Crossref]